What changed in this filing

/stocks — the workspaceLOADING

Item 7. Management’s Discussion and Analysis

2024-07-25 compared with 2023-09-14 · 747 added, 235 removed, 256 unchanged (79% of the section changed)

7 unchanged sentences

Bag Americas acquired 2,500 shares of common stock of Lazex for $332,239.

On September 16, 2019, SBL transferred its ownership of

Slinger Bag Americas to Lazex in exchange for the 2,000,000 shares of Lazex acquired on August 23, 2019.

As a result of these transactions,

Lazex owned 100% of Slinger Bag Americas and the sole shareholder of SBL owned 2,000,000 shares of common stock (approximately 82%) of

Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.

On September 16, 2019, SBL transferred its ownership of Slinger

Bag Americas to Lazex in exchange for the 2,500 shares of Lazex acquired on August 23, 2019.

As a result of these transactions, Lazex

owned 100% of Slinger Bag Americas and the sole shareholder of SBL owned 2,500 shares of common stock (approximately 82%) of Lazex.

September 13, 2019, Lazex changed its name to Slinger Bag Inc.

October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (“Slinger Bag Canada”) a Canadian company

6 unchanged sentences

February 25, 2020, the Company increased the number of authorized shares of common stock from 75,000,000 to 300,000,000 via a four-to-one

forward split of its outstanding shares of common stock.

forward split of its outstanding shares of common.

All share and per share information contained in this report have been retroactively

adjusted to reflect the impact of the stock split.

Effective June 27, 2024, the Company increased the number of authorized

shares of common stock from 300,000,000 to 1,000,000,000.

June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a 100% ownership

2 unchanged sentences

(“Gameface”).

of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company.

of the share purchase agreement, Gameface became a wholly owned subsidiary of the Company.

February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd.

1 unchanged sentence

(the “Shareholders’ Representative”).

As a result of the merger agreement, PlaySight became a wholly owned subsidiary

As a result of the merger agreement, PlaySight would become a wholly owned subsidiary

of the Company.

April 2022, the Company determined that the technology utilized in the Foundation Sports acquired entity would take substantially more

financial resources and more time to bring to market and achieve profitability than originally anticipated.

As a result, the goodwill

and intangible assets related to Foundation Sports were fully impaired as of April 30, 2022, resulting in an impairment loss of $3,486,599.

In addition, during April 2022 the Company decided to sell a portion of Foundation Sports.

The Company continued to classify Foundation

Sports in continuing operations, until December 5, 2022 when it sold 75% of Foundation Sports back to the original owners at which time

it deconsolidated this subsidiary and recorded a loss on the sale.

The Company also determined to dispose of the PlaySight entity during

the year ended April 30, 2023.

The Company completed the sale in November 2022 and recorded a loss on the sale at that time.

April 2022, the Company changed its domicile from Nevada to Delaware.

On April 7, 2022, the Company effected a name change to Connexa

Sports Technologies Inc.

We also changed our ticker symbol, “CNXA”.

Connexa is now the holding company under which Slinger

Bag and Gameface reside.

operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL and Gameface are collectively referred

to as the “Company.”

June 14, 2022, the Company effected a 1-for-10 reverse stock split, where the Company’s common stock began to trade on a reverse

6 unchanged sentences

stock on the Nasdaq Capital Market.

On November 17, 2022, Gabriel

Goldman and Rohit Krishnan resigned from the board of directors of the Company.

Gabriel and Rohit were members of the audit and compensation

November 17, 2022, Gabriel Goldman and Rohit Krishnan resigned from the board of directors of the Company.

Gabriel and Rohit were members

of the audit and compensation committees.

Gabriel Goldman was a member of the Company’s Nominating and Corporate Governance Committee.

Neither Gabriel nor Rohit

advised the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.

On December 5, 2022, the Company

assigned 75% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted him the right for a period of

three years to purchase the remaining 25% of its Foundation Sports membership interests for $500,000 in cash.

As of December 5, 2022,

the results of Foundation Sports were no longer be consolidated in the Company’s financial statements, the Company recorded a loss

on the sale and the investment is now accounted for as an equity method investment.

On December 5, 2022, the Company analyzed this investment

and established a reserve for the investment at the full amount of $500,000.

On November 27, 2022, the Company entered into a share purchase

agreement (the “Agreement”) with PlaySight, Chen Shachar and Evgeni Khazanov (together, the “Buyer”) pursuant

to which the Buyer purchased 100% of the issued and outstanding shares of PlaySight from the Company in exchange for (1) releasing the

Company from all of PlaySight’s obligations towards its vendors, employees, tax authorities and any other (past, current and future)

creditors of PlaySight;

(2) waiver by the Buyer of 100% of the personal consideration owed to them under their employment agreements

in the total amount of U.S.

$600,000 (which would have been increased in December 2022 to U.S.

and (3) cash consideration

Neither Gabriel nor Rohit advised the Company of any disagreement with the Company on any matter relating to its operations, policies

or practices.

November 27, 2022, the Company entered into a share purchase agreement (the “Agreement”) with PlaySight, Chen Shachar and

Evgeni Khazanov (together, the “Buyer”) pursuant to which the Buyer purchased 100% of the issued and outstanding shares of

PlaySight from the Company in exchange for (1) releasing the Company from all of PlaySight’s obligations towards its vendors, employees,

tax authorities and any other (past, current and future) creditors of PlaySight;

(2) waiver by the Buyer of 100% of the personal consideration

owed to them under their employment agreements in the total amount of U.S.

$600,000 (which would have been increased in December 2022

and (3) cash consideration of U.S.

$2 million to be paid to the Company as follows:

3 unchanged sentences

December 31, 2024.

The Buyer timely elected to extend the maturity date of the Promissory Note to December 31, 2024.

Promissory Note can be partially paid over the time, but in the event it is not paid in full by December 31, 2024, then the remaining

9 unchanged sentences

The Company and the Buyer have agreed that the identity of the Appraiser shall be Murray Devine Valuation Advisers, to the extent

their cost of the appraisal shall not be higher than the cost of other appraisers from the big 4 accounting firms (i.e., E&Y,

their cost of the appraisal shall not be higher than the cost of other appraisers from the big 4 accounting firms (i.e.

KPMG, PWC and Deloitte).

The Company and the Buyer have agreed to split the cost of the Appraiser.

Company also released PlaySight from all of its obligations (except for those created by the Agreement) in respect of the Company,

Company has also released PlaySight from all of its obligations (except for those created by the Agreement) in respect of the Company,

including any inter-company debts on the books, and the Buyer has released the Company from all of its obligations (except for those

created by the Agreement) in respect of PlaySight and the Buyer.

total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 in the year ended April 30, 2023.

In April 2023, the Company determined that the technology utilized in Gameface would take substantially more financial resources and

more time to bring to market and achieve profitability than originally anticipated.

As a result, the goodwill and intangible assets related

to Gameface were fully impaired as of April 30, 2023, resulting in an impairment loss of $11,421,817.

On September 13, the Company held

a special meeting of stockholders in which the following items were approved:

(i) the issuance of (i) 1,018,510 shares of the our common

stock, par value $0.001 per share, that were issued on October 3, 2022, and, (ii) 11,802,002 shares of our common stock issuable upon

exercise of Pre-Funded Warrants at an exercise price of $0.00001 per share, (iii) 12,820,512 shares of common stock issuable upon the

exercise of 5-Year Warrants at an exercise price of $0.39 per share, (iv) 25,641,024 shares of common stock issuable upon the exercise

of 7.5 Year Warrants at an exercise price of $0.43 per share and (v) 18,099,548 shares of our common stock issuable upon the exercise

of 5.5 Year Warrants at an at an exercise price per share equal to $0.221 per share to Armistice Capital Master Fund Ltd and (ii) a reverse

stock split of our common stock within a range of one (1)-for-ten (10) to one (1)-for-forty (40) (“Reverse Stock Split”),

with the Board of Directors of the Company to set the specific ratio and determine the date for the reverse split to be effective and

any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at

any time within 12 months of the special meeting date.

reason for the entry into the Agreement and the transactions contemplated thereby was to eliminate the need for the Company to provide

further financing for PlaySight’s operations.

December 5, 2022, the Company assigned 75% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted

him the right for a period of three years to purchase the remaining 25% of its Foundation Sports membership interests for $500,000 in

As of December 5, 2022, the results of Foundation Sports will no longer be consolidated in the Company’s financial statements,

and the investment was accounted for as an equity method investment.

On December 5, 2022, the Company analyzed this investment and established

a reserve for the investment at the full amount of $500,000.

The Company intends to enter into a database access and marketing agreement

with Foundation Sports pursuant to which Foundation Sports will (i) provide the Company with sporting or racquet facility information

and contact data of its customers (subject to applicable law) and (ii) publish any promotional content, call to action, survey or similar

promotional communications provided by the Company to Foundation Sport’s customers for its Customers to promote said material to

their extended network of consumers in exchange for 7% of any gross revenue to be generated from such activities.

March 7, 2023, Slinger Bag entered into an exclusive distribution agreement for Padel Tennis with a company located in Valencia, Spain

called with Desarrollo y Promocion de Padel S.L.

This agreement is contracted to deliver approximately $15 million in revenue by the

November 16, 2023, the Company entered into an agreement with Agile Capital Funding (the “ACF Agreement”) pursuant to which

the Company sold $693,500 in future receivables to ACF (the “ACF Receivable Amount”) in exchange for $450,000 in cash.

Company agreed to pay ACF $28,895.83 each week until the ACF Receivable Amount is paid in full.

order to secure payment and performance of the Company’s obligations to ACF under the ACF Agreement, the Company granted to ACF

a security interest in the following collateral:

all present and future accounts receivable.

The Company also agreed not to create, incur,

assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

previously disclosed on the Current Report on Form 8-K furnished with the SEC on September 9, 2020, the Company entered into a service

agreement dated September 7, 2020 (the “YK Employment Agreement”) with Yonah Kalfa, the Company’s chief innovation

officer and member of the Company’s board of directors.

Pursuant to Sections 2.1(a) and 2.1(b) of the YK Employment Agreement,

the Company owes Mr.

Kalfa $1,137 in salary (the “Salary Compensation”) through January 31, 2024 to Mr.

Company was unable to pay Mr.

Kalfa any of the compensation in cash and, given Mr.

Kalfa’s extraordinary contribution to the Company,

pursuant to Section 2.1(b) of the YK Employment Agreement, on January 20, 2024 the Company agreed to pay $1 million of the $1.137 million

owed (with Mr.

Kalfa waiving the right to receive the $137,000 balance) via an issuance of shares of Common Stock as memorialized by

that certain Deferred Payment Conversion Agreement with Mr.

Kalfa, dated January 20, 2024 (the “2024 Agreement”).

Agreement sets forth the price per share of the shares to be issued (267,380), the number of shares to be issued using that price ($3.74),

and the amount due to Mr.

Kalfa through January 31, 2024.

to administrative delays, the Company did not issue the shares in January.

Rather, on March 15, 2024, the Company issued 220,265 shares

of Common Stock.

This is the amount of stock owed for a $1 million payment at a conversion price of $4.54, which was the closing price

of the Common Stock on March 13, 2024 (and a higher price than the closing price on March 14, 2024).

shareholder approval was required for the issuance of the 220,265 shares because it was less than 20% of the number of the Company’s

outstanding shares of Common Stock as of March 14, 2024 and was issued at a price per share ($4.54) above the Minimum Price as defined

under Nasdaq Listing Rule 5635(d).

Company sought and obtained shareholder approval, pursuant to Nasdaq Listing Rule 5635(c), to issue the balance of 47,115 shares (267,380

minus 220,265) to Mr.

Shares were issued on May 24, 2024 without registration under the Securities Act of 1933, as amended (the “Securities Act”),

in reliance on the exemption provided by Section 4(a)(2) of the Securities Act as a transaction not involving a public offering.

January 20, 2024, the Company agreed to issue to Mike Ballardie, the Company’s chairman of the board and chief executive officer,

warrants to purchase 317,514 shares of common stock (the “MB Warrants”) at an exercise price of $0.02 per share and with

a term of 10-years as compensation for his extraordinary contribution to the company, in exchange for Mr.

Ballardie’s waiver of

his right to receive any bonus payments as described in clause 2.2 of his service agreement with Slinger Bag International (UK) Limited

dated 1 November 2020 (the “Service Agreement”) to which he would otherwise be entitled to receive through January 31, 2024.

and Recent Transactions

March 18, 2024, the Company entered into a share purchase agreement (the “Share Purchase Agreement”) and a share exchange

agreement (the “Share Exchange Agreement,” and together with the Share Purchase Agreement, the “Agreements”)

to acquire a total of 70% of the issued and outstanding ordinary shares of Yuanyu Enterprise Management Co., Limited (“YYEM”),

a Hong Kong company, from the sole shareholder of YYEM, Mr.

Hongyu Zhou (the “Seller”), for a combined $56 million.

The consummation

of the transactions contemplated in the Agreements will result in a change in control of the Company as the shareholders of YYEM will

become the owners 82.4% of the issued and outstanding shares of common stock of the Company (the “Common Stock”).

of this transaction, as further described below under the heading of “The Separation Agreement”, the Company has agreed to

sell its wholly owned subsidiary, Slinger Bag Americas Inc., to a newly established entity to be owned by Yonah Kalfa and Mike Ballardie.

Acquisition Structure

to the Share Purchase Agreement, the Company agreed to purchase, and the Seller agreed to sell, 2,000 ordinary shares of YYEM, representing

20% of the issued and outstanding ordinary shares of YYEM, for the purchase price of $16,500,000 (the “Share Purchase Consideration”),

payable in cash (the “Share Purchase Transaction”).

The Share Purchase Transaction closed on March 20, 2024.

to the Share Exchange Agreement, the Company has agreed to purchase, and the Seller has agreed to sell, 5,000 ordinary shares of YYEM,

representing 50% of the issued and outstanding ordinary shares of YYEM, for 8,127,572 newly issued shares of Common Stock to the Seller

(the “Share Exchange Transaction,” and together with the Share Purchase Transaction, the “Transactions”).

shares are expected to represent 82.4% of the issued and outstanding shares of Common Stock as of the date of the closing of the Share

Exchange Transaction (the “Share Exchange Consideration”).

Exchange Shares will be issued without registration under the Securities Act, in reliance upon a safe harbor for offshore transactions

or an exemption from registration for transactions not involving a public offering and, as such, will constitute “restricted securities”

within the meaning of Rule 144 under the Securities Act.

Under Rule 144, the Exchange Shares generally may not be offered or sold publicly

unless they have been held for at least six months and subject to other conditions.

connection with the Exchange Transaction, the Company has agreed that at or prior to the closing date of the Acquisition (the “Closing

Date”), it will enter into a separation agreement to sell, transfer and assign all or substantially all of its legacy business,

assets and liabilities related to or necessary for the operations of its “Slinger Bag” business or products (the “Legacy

Business”) to a newly established entity (“NewCo”), and that after the Closing Date, NewCo will have the sole right

to and obligations of the Legacy Business and will be liable to the Company for any losses arising from third-party claims against the

Company that arise from liabilities related to the Legacy Business (the “Separation”).

NewCo will be owned by Yonah Kalfa

and Mike Ballardie.

a pro forma basis, as of April 30, 2024, the Legacy Business’ assets were approximately $5.1 million (which represents the

assets of the Company as of January 31, 2024, minus, on a pro forma basis, the $16.5 million used for the purchase of 20% ownership

of YYEM in April 2024), and the liabilities of the Legacy Business were $12.0 million (which represents the liabilities of the

Company as of April 30, 2024).

Accommodations

an inducement to the Company to complete the Transactions, the Agreements provide that aggregate payments of (a) $4,500,000 shall be

made to the Company in cash by YYEM and (b) $500,000 shall be made to NewCo (as defined under the header “The Separation Agreement”)

in cash by YYEM, as follows:

(i) $800,000 payable within two (2) business days of the date of the Agreements;

(ii) $1,200,000 payable

within three (3) business days of the Company changing its ticker symbol from “CNXA” to “YYAI,” or such other

symbol as the parties may agree;

(iii) $2,000,000 payable at the Closing and (iv) $500,000 to be paid within 30 days from the Closing

Date and paid to NewCo.

Out of the $4,500,000, the Company paid $2,142,857 to certain companies for arranging the Transactions.

following the Acquisition

or after the Closing, the board of directors of Connexa (the “Board”) shall comprise those individuals designated by YYEM

Seller, and all current members of the Board shall resign with such resignation being effective on the later of the Closing or the appointment

or election of the new directors.

Share Exchange, as amended, provides that:

or before the Closing Date, the Company shall obtain approval from holders of shares of Common Stock for the Share Exchange Transaction

and other matters related to the Share Exchange Transaction.

Such stockholder approval was received on May 15, 2024;

or before the Closing Date, the Company shall obtain approval from Nasdaq for the Reverse Stock Split of the Common Stock at a ratio

to be determined by the parties;

a condition to Closing, from the date of the Exchange Agreement through the Closing Date, the existing shares of Common Stock shall

have been continually listed on Nasdaq, and the Company shall have not received a determination from Nasdaq indicating that the Common

Stock will be delisted from Nasdaq;

Company and YYEM shall cooperate to effectuate a reverse stock split, obtain approval from Nasdaq of a new listing application to

be submitted to Nasdaq in connection with the Share Exchange Transaction, and provide such information as is necessary for the Company

to obtain shareholder approval of the Share Exchange Transaction and other matters relating thereto.

The shareholder approval was

obtained on May 15, 2024, and a new listing application was submitted to Nasdaq in May 2024, which is currently under review by Nasdaq.

cannot provide assurance as to when, or if, all of the closing conditions will be satisfied or waived by the relevant party.

date of this prospectus, we have no reason to believe that any of the conditions will not be satisfied.

the Closing, the Company shall deliver to YYEM Seller the following:

of all resolutions of the Board authorizing the execution, delivery, and performance of the Exchange Agreement and the other agreements,

instruments, and documents required to be delivered in connection with the Exchange Agreement or at the Closing to which the Company

is a party and the consummation of the transactions contemplated hereby and thereby;

Exchange Shares;

documents, instruments, agreements and certificates that may be deliverable in connection with the performance or fulfillment of

the conditions under Section 6.01 and Section 6.03 of the Exchange Agreement that are relevant to the Company;

duly executed bought and sold note, as applicable;

other documents, instruments and writings which may be reasonably requested by YYEM Seller to be delivered by the Company at or prior

to the Closing pursuant to the Exchange Agreement.

the Closing, YYEM Seller shall deliver to the Company the following:

of the Closing Cash Payment (as defined in the Exchange Agreement);

good standing certificate (or its equivalent) for YYEM from the relevant governmental authority of Hong Kong, if applicable, and

each other jurisdiction where YYEM is qualified, registered, or authorized to do business, if any;

the YYEM shares are represented by certificates, such certificates duly endorsed for transfer by YYEM Seller, as applicable;

counterpart to any consents required in connection with the transactions contemplated by the Exchange Agreement;

documents, instruments, agreements and certificates that may be deliverable in connection with the performance or fulfillment of

the conditions under Section 6.01 and Section 6.02 of the Exchange Agreement that are relevant to YYEM Seller;

duly executed bought and sold note as may be required under the law of Hong Kong;

other documents, instruments and writings which may be reasonably requested by YYEM Buyer to be delivered by YYEM Seller and YYEM

at or prior to the Closing pursuant to the Exchange Agreement.

Exchange Agreement may be terminated by mutual written consent of the Company and the YYEM Seller at any time before the Closing or by

either the Company or the YYEM Seller at any time before the Closing if the Share Exchange Transaction has not been consummated by the

date that is 180 days from the date of the Exchange Agreement (the “Termination Date”) or if any party breaches the Exchange

Agreement with respect to the closing conditions and such breaches cannot be cured by the Termination Date.

If the Exchange Agreement

is terminated by the Company unilaterally and of its own volition other than due to the aforementioned termination conditions, the Company

shall be liable for a termination fee in the amount of three times the fees and costs incurred by the YYEM Seller in connection with

the Share Exchange Transaction up to a maximum amount in the aggregate of $600,000, with certain exceptions, including, but not limited

to lack of SEC or Nasdaq approval of the Share Exchange Transaction or lack of approval from holders of shares of Common Stock.

Company’s Board and stockholders have approved the Proposed Reverse Stock Split of its Common Stock within a range of 1-for-10

to 1-for-100, with the Board having set the specific ratio at 1-20 and determined the date for the Proposed Reverse Stock Split to be

effective to be June 27, 2024.

June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (“Meged”) pursuant to which

the Company sold $315,689 in future receivables to Meged (the “Meged Receivables Purchased Amount”) to in exchange for payment

to the Company of $210,600 in cash less fees of $10,580.

The Company agreed to pay Meged $17,538 each week until the Meged Receivables

Purchased Amount is paid in full.

September 19, 2023, the Company entered into an agreement with Meged (the “Second Meged Agreement”) pursuant to which the

Company sold $423,000 in future receivables to Meged (the “Meged Second Receivable Amount”) in exchange for paying the then

outstanding balance of $70,153 of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in cash

for general purposes.

The Company agreed to pay Meged $15,107 each week until the Meged Second Receivable Amount was paid in full.

order to secure payment and performance of the Company’s obligations to Meged under the Second Meged Agreement, the Company granted

to Meged a security interest in all accounts receivable and all proceeds therefrom as such term is defined by Article 9 of the Uniform

Commercial Code (UCC).

The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on

or with respect to any of such collateral.

August 7, 2023, the Company entered into an agreement with UFS (the “UFS Agreement”) pursuant to which the Company sold $797,500

in future receivables (the “UFS Second Receivables Purchased Amount”) to UFS in exchange for payment to the Company of $550,000

in cash less fees of $50,000.

The Company agreed to pay UFS $30,000 each week until the UFS Second Receivables Purchased Amount was paid

order to secure payment and performance of the Company’s obligations to UFS under the UFS Agreement, the Company granted to UFS

a security interest in all accounts receivable and all proceeds therefrom as such term is defined by Article 9 of the Uniform Commercial

The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect

to any of such collateral.

Meeting of Stockholders

September 13, 2023 the Company held a special meeting of stockholders in which the following items were approved:

(i) the issuance of

(i) 1,274 shares of the our common stock, par value $0.001 per share, that were issued on October 3, 2023, and, (ii) 14,753 shares of

our common stock issuable upon exercise of Pre-Funded Warrants at an exercise price of $0.00002 per share, (iii) 16,026 shares of common

stock issuable upon the exercise of 5-Year Warrants at an exercise price of $312 per share, (iv) 32,052 shares of common stock issuable

upon the exercise of 7.5 Year Warrants at an exercise price of $344 per share and (v) 22,625 shares of our common stock issuable upon

the exercise of 5.5 Year Warrants at an at an exercise price per share equal to $1,768per share to Armistice Capital Master Fund Ltd

and (ii) a reverse stock split of our common stock within a range of one (1)-for-ten (10) to one (1)-for-forty (40) (“Reverse Stock

Split”), with the Board of Directors of the Company to set the specific ratio and determine the date for the reverse split to be

effective and any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders,

at any time within 12 months of the special meeting date.

September 25, 2023, as a result of the shareholder approval obtained at the special meeting of stockholders on September 13, 2023 and

the Reverse Stock Split, the aggregate number of Pre-Funded Warrants, 5-Year Warrants, 5.5-Year Warrants and 7-Year Warrants increased

from 85,455 to 471,348 due to certain adjustments that were required to be made by the terms of the relevant warrants in the event of

receipt of shareholder approval and the occurrence of the Reverse Stock Split.

Transactions from September 2023 to April 2024

September 18, 2023 through April 30, 2024, the Company issued Armistice 9478,709 shares of Common Stock related to the exercise of the

pre-funded warrants.

October 11, 2023, the Company, the Lenders and the Agent (as defined in the LSA) entered into a loan and security modification agreement

to allow for an additional loan of $1,000,000 pursuant to the loan and security modification agreement.

In addition, on October 11, 2023,

the Company agreed to issue warrants to purchase up to 8,460 shares of Common Stock at an exercise price of $138 per share (the “October

December 6, 2023, the Company entered into an inducement offer letter agreement (the “Inducement Letter”) with Armistice

with regard to certain of the Company’s existing warrants to purchase up to a total of 248,611 shares of Common Stock, consisting

(i) 70,508 shares of Common Stock issuable upon the exercise of warrants issued on September 28, 2022 each at an exercise price of

$35.46 per share with a term of five year (the “September 2022 Five Year Warrants”);

(ii) 155,479 shares of Common Stock

issuable upon the exercise of warrants issued on September 28, 2022 each at an exercise price of $70.92 per share with a term of seven

and one half years (the “September 2022 Seven and a Half Year Warrants”);

and (iii) 22,625 shares of Common Stock issuable

upon the exercise of warrants issued on January 6, 2023 (the “January 2023 Warrants” and, together with the September 2022

Five Year Warrants and the September 2022 Seven and a Half Year Warrants, the “2022 and 2023 Warrants”).

to the Inducement Letter, Armistice agreed to exercise for cash the 2022 and 2023 Warrants to purchase an aggregate of 248,611 shares

of Common Stock at a reduced exercise price of $5.88 per share in consideration of the Company’s agreement to issue common stock

purchase warrants to purchase up to an aggregate of 497,221 shares of Common Stock (the “December Warrants”).

received aggregate gross proceeds of $1,461,827.68 from the exercise of the 2022 and 2023 Warrants by the Holder, before deducting offering

expenses payable by it.

The transaction closed on December 7, 2023.

resale of the shares of the Common Stock underlying the 2022 and 2023 Warrants and 224,472 shares of Common Stock owned by Sapir LLC,

a consultant engaged by the Company were registered pursuant to an existing registration statement on Form S-1 (File No.

declared effective by the Securities and Exchange Commission (the “SEC”) on December 4, 2023.

of February 21, 2024, the total amount owed pursuant to the Note was $3,197,335.65.

Of this amount, the Company received gross proceeds

of $3 million from the Lenders.

February 21, 2024, the Company and the Lenders and the Agent entered into a Waiver, Warrant Amendment and Second Loan and Security Modification

Agreement (the “Waiver, Amendment, and Modification Agreement”).

to the Waiver, Amendment, and Modification Agreement, the Lenders and the Agent agreed to waive certain events of default with regard

to certain covenants and obligations the Company had pursuant to (a) that certain registration rights agreement between the Company and

the Lenders and the Agent entered into in September 2022, (b) the LSA (as modified), and (c) the Inducement Letter.

to the Waiver, Amendment, and Modification Agreement, the Company and the Lenders and the Agent agreed to modify the Loan and Security

Agreement such that the Note is now convertible into up to 499,584 shares of Common Stock based on the agreed to conversion price of

The Company believed that the $6.40 conversion price meets the definition of “Minimum Price” in Nasdaq Listing Rule

to the Waiver, Amendment, and Modification Agreement, the Lenders and the Agent agreed to use their reasonable best efforts to voluntarily

convert all amounts owed under the Note on or prior to the last trading day before the trading day on which the next meeting of the Company’s

shareholders would take place.

to the Waiver, Amendment, and Modification Agreement, the Company and the Lenders and the Agent agreed that following shareholder approval,

which the Company obtained on May 15, 2024, the October Warrants and December Warrants have been amended to lower the exercise price

of such warrants to $3.20 per share.

to the Waiver, Amendment, and Modification Agreement, the Company agreed that Slinger Bag Americas Inc., a Delaware subsidiary of the

Company (“Slinger”) would, within ten (10) business days of the six month anniversary of the effectiveness of the registration

statement on Form S-1 registering the shares of Common Stock issuable pursuant to the conversion of the Note (the “Effectiveness

Date”), pay in cash to the Lenders and the Agent the difference, if any, between (i) $6 million (the “Guaranteed Amount”)

and (ii) the combined gross proceeds realized by the Lenders and the Agent from its sale of the shares of Common Stock issued pursuant

to (a) conversions of the Note and (b) exercises of the October Warrants and December Warrants(the “Realized Amount”).

is obligated to fund an escrow account with $2 million within ten (10) weeks of February 21, 2024.

The Company and the Lenders and the

Agent also agreed that if, due to a Force Majeure Event, the Lenders and the Agent had not fully converted the Note prior to the six-month

anniversary of the Effectiveness Date, the Company would repurchase the Note and the October Warrants and December Warrants by paying

in cash to the Lenders and the Agent the difference, if any, between the Guaranteed Amount and the Realized Amount.

to the Waiver, Amendment, and Modification Agreement, the Company and the Lenders and the Agent agreed that once the Note was fully repaid

(either via a combination of cash payments and conversions into shares of Common Stock or just via conversions into shares of Common

Stock) all liens and security interests of the Lenders and the Agent in any and all of the property of the Company and the Guarantors

(as defined in the Waiver, Amendment, and Modification Agreement) would be automatically released and terminated, including without limitation,

any liens and security interests evidenced by Uniform Commercial Code financing statements.

to the Waiver, Amendment, and Modification Agreement, the Company agreed to prepare and file a registration statement on Form S-1 registering

the shares of Common Stock issuable pursuant to the conversion of the Note with the SEC within five (5) business days of February 21,

2024 and use commercially reasonable best efforts to cause such registration statement to be declared effective by the SEC as soon as

practical thereafter and, in any event, within thirty (30) calendar days of February 21, 2024.

A registration statement was filed and

became effective on March 1, 2024 in compliance with this obligation.

April 15, 2024, the Company acknowledged and agreed to the entrance into a warrant purchase agreement (the “Morgan WPA”)

by Armistice and Morgan Capital LLC (“Morgan”) pursuant to which Armistice sold the October and December 2023 Warrants to

Morgan for $2,500,000 in cash.

Pursuant to the Morgan WPA, Armistice agreed that the obligation of Slinger Bag Americas to, within 10

Business Days of the six month anniversary of the Waiver, Amendment, and Modification Agreement, pay in cash to Armistice the difference,

if any, between (i) $6 million and (ii) the combined gross proceeds to be realized by the Holder from its sale of the Company’s

common stock issued pursuant to (a) conversions of the note (which as of the date hereof has been fully converted into shares of the

Company’s common stock) and (b) exercises of the Warrants would be terminated and of no further effect and force.

pursuant to the Morgan WPA, Armistice agreed that the obligation of Slinger Bag Americas to maintain an escrow account with its counsel

in the amount of no less than $2,000,000 would be terminated and of no further effect and force.

Armistice further agreed that any and

all liens and security interests of Armistice in any and all of the property of the Company and the Guarantors (as such terms are defined

in the Waiver, Amendment, and Modification Agreement) would be automatically released and terminated, including without limitation, any

liens and security interests evidenced by Uniform Commercial Code financing statements.

October 12, 2023, the Board of Directors of the Company approved an amendment to the Bylaws of the Company to reduce the percentage of

shares of stock, issued and outstanding and entitled to vote, to be present in person or represented by proxy in order to constitute

a quorum for the transaction of any business from a majority to thirty-three and one third percent (33 1/3%).

Issuance to Sapir

November 14, 2023, the Company issued 11,224 shares of Common Stock to Sapir LLC.

Sapir LLC is controlled by Aitan Zacharin, an investor

relations and financial structuring consultant to the Company who is a party to an amended and restated consulting agreement with the

Company dated April 30, 2020 (the “AZ Consulting Agreement”).

Pursuant to the AZ Consulting Agreement, the Company owed Mr.

Zacharin $127,500 as consulting fee compensation through November 30, 2023 (the “Consulting Fee Compensation”).

the Company granted Mr.

Zacharin $127,500 as discretionary compensation (“Discretionary Compensation”) pursuant to Section

2.1(d) of the AZ Consulting Agreement.

In consideration of the Consulting Fee Compensation and the Discretionary Compensation, the issuance

of shares of Common Stock consisted of (i) 8,017 shares of Common Stock as payment of the Consulting Fee Compensation, and (ii) 3,207

shares of Common Stock as payment of the Discretionary Compensation.

January 30, 2024, the Company received a letter from the staff of the Nasdaq Stock Market confirming that following the receipt of a

an investment of $16.5 million as disclosed in the Company’s current report filed on Form 8-K on January 24, 2024 (i) the Company

has regained compliance with the minimum shareholder equity requirement in Listing Rule 5550(b)(1) (the “Equity Rule”), as

required by the Nasdaq Hearing Panel’s (“Panel”) decision dated April 12, 2023, as amended, and (ii) in application

of Listing Rule 5815(d)(4)(B), the Company will be subject to a mandatory panel monitor for a period of one year from the date of such

If, within that one-year monitoring period, the Nasdaq Listing Qualifications staff (the “Staff”) finds that the

Company is no longer in compliance with the Equity Rule, then, notwithstanding Rule 5810(c)(2), the Company will not be permitted to

provide Staff with a plan of compliance with respect to such deficiency and the Staff will not be permitted to grant additional time

for the Company to regain compliance with respect to such deficiency, nor will the Company be afforded an applicable cure or compliance

period pursuant to Rule 5810(c)(3).

Instead, the Staff will issue a Delist Determination Letter and the Company will have an opportunity

to request a new hearing with the initial Panel or a newly convened Hearings Panel if the initial Panel is unavailable.

The Company will

have the opportunity to respond/present to the Hearings Panel as provided by Listing Rule 5815(d)(4)(C) and the Company’s securities

may at that time be delisted from Nasdaq.

is further reported that, in application of Listing Rule 5815(d)(4)(B), the Company is also subject to a mandatory panel monitor in respect

of its periodic filing requirements in Listing Rule 5250(c)(1) (the “Periodic Filing Rule”) for a period of one year from

October 11, 2023.

If, within that one-year monitoring period, the Staff finds the Company again out of compliance with the Periodic Filing

Rule, notwithstanding Rule 5810(c)(2), the Company will not be permitted to provide Staff with a plan of compliance with respect to that

deficiency and Staff will not be permitted to grant additional time for the Company to regain compliance with respect to that deficiency,

nor will the company be afforded an applicable cure or compliance period pursuant to Rule 5810(c)(3).

Instead, Staff will issue a Delist

Determination Letter and the Company will have an opportunity to request a new hearing with the initial Panel or a newly convened Hearings

Panel if the initial Panel is unavailable.

The Company will have the opportunity to respond/present to the hearing panel as provided

by Listing Rule 5815(d)(4)(C) and the Company’s securities may at that time be delisted from Nasdaq.

December 12, 2023, the Company received a letter (the “Notice”) from the Staff informing the Company that because the closing

bid price for the Common Stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company was not in compliance with

the minimum bid price requirement for continued listing on Nasdaq as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum

Bid Price Requirement”).

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was given a period of 180 calendar days

from December 12, 2023, or until June 10, 2024, to regain compliance with the Minimum Bid Price Requirement.

11 June , 2024 the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC

(“ Nasdaq ”) indicating that (i) the Company did not regained compliance with the Rule within the prescribed time

period and is not eligible for a second 180-day remediation period.

Specifically, the Company did not comply with the $5,000,000

minimum stockholders’ equity initial listing requirement for The Nasdaq Capital Market under the Equity Standard and (ii)

unless the Company requests an appeal by June 18, 2024, of this determination, Nasdaq has determined that the Company’s

securities will be scheduled for delisting from Nasdaq and will be suspended at the opening of business on June 21, 2024, and a Form

25-NSE will be filed with the Securities and Exchange Commission (the “ SEC ”), which will remove the

Company’s securities from listing and registration on The Nasdaq Stock Market (the “ Delisting

Determination ”).

The Company appealed

of the Delisting Determination on June 18, 2024 by requesting a hearing before the Panel to stay the suspension of the Company’s

The hearing panel date was set for July 25, 2024.

Through the subsequent filing of the Form 25-NSE with the SEC.

27, 2024, the Company effected a 1-20 reverse stock split, which brought its share price to $8.31, which, in turn, caused the Company

to regain compliance with the Minimum Bid Price Requirement and on July 11, 2024, the company’s closing bid price was in excess

of $1 for a continuous 10-day trading period.

On July 18, 2024, the Company received Nasdaq confirmation that the hearing has been cancelled

and the Delisting Determination has been withdrawn.

can be no assurance that the Company will be able to satisfy Nasdaq’s continued listing requirements.

May 1, 2024, the Company received a letter from the Nasdaq indicating that, due to the Company’s failure, in violation of Listing

Rules 5620(a) and 5810(c)(2)G), to hold an annual meeting of shareholders within twelve months of the end of the Company’s fiscal

year end of April 30, 2023, it no longer complies with the Nasdaq’s Listing Rules for continued listing.

Under Nasdaq Rules, the

Company has 45 calendar days from May 1, 2024 to submit a plan to regain compliance and if the Nasdaq accepts such plan, Nasdaq can grant

an exception of up to 180 calendar days from the fiscal year end, or until October 28, 2024, to regain compliance.

On May 17, 2024, Nasdaq

notified the Company that based on the Company’s current report on Form 8-K filed on May 17, 2024, the Company’s proxy distributed

on May 2, 2024, and the annual meeting of the stockholders held on May 15, 2024, it has regained compliance with the Nasdaq Listing Rules

for continued listing.

January 2024 Offering

January 19, 2024, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with three

investors (the “January 2024 Investors”) for the issuance and sale to each investor of (i) 116,510 shares of Common Stock

and (ii) the Pre-Funded Warrants to purchase an aggregate of 1,258,490 shares of Common Stock at a combined purchase price of $0.40 per

share of Common Stock for an aggregate amount of approximately $16.5 million.

The Pre-Funded Warrants have an exercise price of $0.0002

per share of Common Stock and are exercisable beginning on May 15, 2024, the date stockholder approval was received and effective, allowing

exercisability of Pre-Funded Warrants under Nasdaq rules until the Pre-Funded Warrants are exercised in full.

The aggregate number of

Shares issued to the January 2024 Investors is 349,530 and the aggregate number of Pre-Funded Warrants is 3,775,470.

April 2024 through May 2024, the Company acknowledged and agreed to the entrance into certain warrant purchase agreements (the “WPAs”)

by the January 2024 Investors and 10 purchasers (the “Pre-Funded Warrants Purchasers”) pursuant to which the January 2024

Investors sold all of the 3,775,470 Pre-Funded Warrants to Pre-Funded Warrants Purchasers for an aggregate amount of $18,877,350 in cash.

Issuance to Smartsports

January 23, 2024, the Company issued 10,000 shares of Common Stock to Smartsports LLC.

Smartsports LLC is an investor relations consultant

to the Company who is a party to a consulting agreement with the Company dated January 23, 2024 (the “Smartsports Consulting Agreement”).

Pursuant to the Smartsports Consulting Agreement, the Company agreed to issue and deliver to Smartsports LLC 10,000 shares of Common

Stock as a consulting fee for the provision of investor relations services (the “Consulting Fee Compensation”) and use its

commercially reasonable efforts to prepare and file with the Securities Exchange Commission a registration statement covering the resale

of all of the shares on Form S-1 as soon as is reasonably practicable.

Agile Capital LLC Agreement

On January 10, 2024, the Company

entered into an agreement with Agile Capital Funding, LLC (the “Agile Jan Agreement”) pursuant to which the Company sold $1,460,000

in future receivables to Agile Capital Funding, LLC (the “Agile Jan Receivable Amount”) in exchange for $1,000,000 in cash.

The Company agreed to pay Agile Capital Funding, LLC (“Agile”) $52,142.86 each week until the Agile Receivable Amount is paid

In order to secure payment and performance of the Company’s obligations to Agile under the Agile Jan Agreement, the Company

granted to Agile a security interest in all present and future accounts receivable.

The Company also agreed not to create, incur, assume,

or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

The proceeds from the sale of future

receivables were used, in part, to pay the outstanding balance of the ACF Receivable Amount (as defined below).

Advance Agreement No.1

January 29, 2024, the Company entered into an agreement with Cedar Advance LLC (the “Cedar Agreement”) pursuant to which

the Company sold $1,183,200 in future receivables to Cedar Advance LLC (the “Cedar Receivable Amount”) in exchange for $752,000

The Company agreed to pay Cedar Advance LLC (“Cedar”) $39,440 each week until the Cedar Receivable Amount is paid

In order to secure payment and performance of the Company’s obligations to Cedar under the Cedar Agreement, the Company

granted to Cedar a security interest in the following collateral:

all present and future accounts receivable.

The Company also agreed

not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

Funding Solutions Agreement

March 6, 2024, the Company entered into an agreement (the “UFS Agreement”) with Unique Funding Solutions (“UFS”)

pursuant to which the Company sold $323,350 in future receivables to UFS (the “UFS Receivable Amount”) in exchange for $200,000

The Company agreed to pay UFS $9,798.49 each week until the UFS Receivable Amount is paid in full.

order to secure payment and performance of the Company’s obligations to UFS under the UFS Agreement, the Company granted to UFS

a security interest in all present and future accounts receivable.

The Company also agreed not to create, incur, assume, or permit to

exist, directly or indirectly, any lien on or with respect to any of such collateral.

Advance Agreement No.

April 3, 2024, the Company entered into an agreement with Cedar (the “Second Cedar Agreement”) pursuant to which the Company

sold $438,000 in future receivables to Cedar (the “Second Cedar Receivable Amount”) in exchange for $285,000 in cash.

Company agreed to pay UFS $14,600 each week until the Second Cedar Receivable Amount is paid in full.

order to secure payment and performance of the Company’s obligations to Cedar under the Second Cedar Agreement, the Company granted

to Cedar a security interest in all present and future accounts receivable.

The Company also agreed not to create, incur, assume, or

permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

Advance Agreement No.

April 22, 2024, the Company entered into an agreement with Cedar (the “Third Cedar Agreement”) pursuant to which the Company

sold $481,800 in future receivables to Cedar (the “Third Cedar Receivable Amount”) in exchange for $310,200 in cash.

Company agreed to pay UFS $18,530.77 each week until the Third Cedar Receivable Amount is paid in full.

order to secure payment and performance of the Company’s obligations to Cedar under the Third Cedar Agreement, the Company granted

to Cedar a security interest in all present and future accounts receivable.

The Company also agreed not to create, incur, assume, or

permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

Company operates in the sports equipment and technology business.

The Company is the owner of the Slinger Launcher, which is comprised

of a portable tennis ball launcher, a portable padel tennis ball launcher and a portable pickleball launcher and Gameface, providing

AI technology and performance analytics.

inception to date, we have been focused on the ball sport market globally.

Our first product, the Slinger Bag Launcher, is a patented,

highly portable, versatile and affordable ball launcher built into an easy to transport wheeled trolley bag.

ball machines have been around since the 1950’s when they were introduced by Rene Lacoste.

Improvements to performance were made

in the 1970’s when Prince started its tennis business on the back of its first product – Little Prince – which was

a vacuum operated ball machine.

In the 1990’s the first battery operated machines came to the market and since that time very little,

if anything, has changed in the structure of ball machines products outside of added computerization.

Typically, the machines being marketed

by traditional ball machine brands are large, cumbersome and awkward to operate.

They are also generally expensive – often well

$1,000 compared to the entry price of $700 for a Slinger Bag Launcher.

We believe that up until the introduction of the Slinger

Bag Launcher, the majority of traditional tennis ball machines were sold to tennis facilities, institutions and tennis teachers, with

only a few being sold directly to tennis playing consumers.

May 15, 2024, the Company held its 2024 annual general meeting of stockholders at which the following items were approved:

nominations of Mike Ballardie, Yonah Kalfa, Kirk Taylor, Stephen Crummey, and Rodney Rapson for election as directors at the Annual

Meeting until the 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified.

appointment of Olayinka Oyebola & Co.

to continue as our independent registered public accounting firm for the fiscal year ended

April 30, 2024.

approval of the issuance of shares of our common stock pursuant to that certain Share Exchange Agreement dated March 18, 2024 (the

“Exchange Agreement”) among the Company, Mr.

Hongyu Zhou (the “YYEM Seller”), and Yuanyu Enterprise Management

Co., Limited (“YYEM”), in exchange for 50% of the issued and outstanding ordinary shares of YYEM.

The Exchange Agreement

is a part of a transaction between the Company, YYEM Seller, and YYEM, whereby the Company agreed to purchase a total of 70% of the

issued and outstanding ordinary shares of YYEM by entering into a share purchase agreement (the “Purchase Agreement”)

and the Exchange Agreement as described in the Company’s Schedule 14A filed on May 2, 2024.

Upon the closing of the Acquisition,

YYEM Seller will be issued the number of Exchange Shares equal to 82.4% of the Company’s issued and outstanding shares of common

stock immediately following the closing of the Acquisition, and Connexa stockholders as of immediately prior to the closing of the

Acquisition will retain the balance of approximately 17.6% of such outstanding shares.

amendment to the Company’s certificate of incorporation to increase the authorized shares of its common stock from 300,000,000

shares to 1,000,000,000 shares.

approval of an amendment to the Company’s certificate of incorporation to authorize a reverse stock split of its common stock

within a range of 1-for-10 to 1-for-100, with the Board of Directors of the Company to set the specific ratio and determine the date

for the Reverse Stock Split to be effective.

approval of the separation of the Company’s “Slinger Bag” business and products and the transactions contemplated

by the separation agreement related to the transaction contemplated by the Exchange Agreement (the “Share Exchange Transaction”)

Once the Share Exchange Transaction is closed, the current board of directors of the Company will resign and will appoint YYEM’s

slate of directors to the board, which will effect of a change of control of the Company, and the current business of the Company,

including its liabilities, will be spun off and sold to a company to be owned and controlled by Yonah Kalfa, the founder of the Slinger

Bag business and an officer and director of the company, and Mike Ballardie, the Company’s current chief executive officer

and director.

The Company’s current shareholders will not have a participation in the Slinger Bag business from the date of

the closing of the Share Exchange Transaction and onward.

approval of the amendment to the exercise price of the Warrants held by Morgan Capital LLC to $3.20 per share.

approval of the issuance of shares of Common Stock to certain investors party to the Company’s securities purchase agreements

entered into in January 2024 when the Company received an investment of $16,500,000 in cash in exchange for the issuance and sale

to each Investor of (i) 116,510 shares of the Company’s common stock (the “Common Stock Shares”) and (ii) pre-funded

warrants (the “Pre-Funded Warrants”) to purchase an aggregate of 1,258,490 shares of the Company’s common stock

(the “Pre-Funded Warrant Shares”) at a combined purchase price of $4 per share of our common stock for an aggregate amount

of approximately $16.5 million.

The Pre-Funded Warrants have an exercise price of $0.0002 per share of Common Stock and became exercisable

on May 15, 2024 allowing exercisability of the Pre-Funded Warrants under Nasdaq rules until the Pre-Funded Warrants are exercised

The aggregate number of Common Stock Shares issued was 349,530 and the aggregate number of Pre-Funded Warrant Shares to

be issued is 3,775,470.

approval of the issuance of 47,116 shares of Common Stock to Yonah Kalfa.

As previously disclosed on the Current Report on Form 8-K

furnished with the SEC on September 9, 2020, the Company entered into a service agreement dated September 7, 2020 (the “YK

Employment Agreement”) with Yonah Kalfa, the Company’s chief innovation officer and a member of the Company’s Board.

Pursuant to Sections 2.1(a) and 2.1(b) of the YK Employment Agreement, the Company owed Mr.

Kalfa $1,137,000 in salary (the “Salary

Compensation”) through January 31, 2024.

The Company was unable to pay Mr.

Kalfa any of the compensation in cash and, given

Kalfa’s extraordinary contribution to the Company, pursuant to Section 2.1(b) of the YK Employment Agreement, the Company

agreed to pay $1 million of the $1.137 million owed (with Mr.

Kalfa waiving the right to receive the $137,000 balance) via an issuance

of shares of Common Stock as memorialized by that certain Deferred Payment Conversion Agreement with Mr.

Kalfa, dated January 20,

2024 (the “2024 Agreement”).

The 2024 Agreement sets forth the price per share of the shares to be issued (267,380), the

number of shares to be issued using that price ($3.74), and the amount due to Mr.

Kalfa through January 31, 2024.

Due to administrative

delays, the Company did not issue the shares in January 2024.

Rather, on March 15, 2024, the Company issued 220,265 shares of Common

This is the amount of stock owed for a $1 million payment at a conversion price of $4.54, which was the closing price of the

Common Stock on March 13, 2024 (and a higher price than the closing price on March 14, 2024).

approval of the issuance of 50,000 shares of Common Stock to each of Yonah Kalfa, Mike Ballardie and Kirk Taylor and 25,000 shares

of common stock to each of Rodney Rapson and Steven Crummey, our directors, for their services and extraordinary contribution to

approval of the issuance of 16,750 shares of Common Stock to each of Juda Honickman, the Company’s chief marketing officer,

and Mark Radom, the Company’s general counsel, for their services and extraordinary contribution to the Company.

approval of the amendment of the 2020 Slinger Bag Inc.

Global Share Incentive Plan to make an additional 1,500,000 shares of the

Common Stock available for the issuance of awards under the plan.

June 27, 2024, the Company effected a 1-20 reverse stock split.

No fractional shares were issued in connection with the reverse stock

split and all such fractional interests were rounded up to the nearest whole number of shares of common stock.

All references to the

outstanding stock have been retrospectively adjusted to reflect this reverse split.

operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL and Gameface are collectively referred

2 unchanged sentences

The Company is the owner of the Slinger Bag Launcher, which is comprised

of a portable tennis ball launcher, a portable padel tennis ball launcher and a portable pickleball launcher and Gameface AI, providing

of a portable tennis ball launcher, a portable padel tennis ball launcher and a portable pickleball launcher and Gameface, providing

AI technology and performance analytics for sports.

87 unchanged sentences

which the determination is made.

Long-lived assets and goodwill related to Gameface in the amount of $11,421,817 were fully impaired

as of April 30, 2023, resulting in an impairment loss.

Company accounts for goodwill in accordance with ASC 350, Intangibles - Goodwill and Other (“ASC 350”).

20 unchanged sentences

Accounting Pronouncements

January 2017, the Financial Accounting Standards Board (“FASB”) issued ASU No.

2017-04, Intangibles – Goodwill and

Other (Topic 350):

Simplifying the Test for Goodwill Impairment (“ASU 2017-04”), which simplifies how an entity is required

to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test.

Under ASU 2017-04, goodwill impairment will

be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount

by which the carrying amount exceeds the reporting unit’s fair value.

The new guidance must be applied on a prospective basis and

is effective for periods beginning after December 15, 2022, with early adoption permitted.

The Company adopted ASU 2017-04 effective

The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

December 2019, the FASB issued Accounting Standards Update (“ASU”), 2019-12, Simplifying the Accounting for Income Taxes ,

which amends ASC 740, Income Taxes (ASC 740).

This update is intended to simplify accounting for income taxes by removing certain

exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740.

is effective for fiscal years beginning after December 15, 2021.

The guidance in this update has various elements, some of which are

applied on a prospective basis and others on a retrospective basis with earlier application permitted.

adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

August 2020, the FASB issued ASU No.

2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging

Contracts in Entity’s Own Equity (Subtopic 815-40):

Accounting for Convertible Instruments and Contracts in an Entity’s Own

ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible

debt instruments and convertible preferred stock.

Limiting the accounting models results in fewer embedded conversion features being

separately recognized from the host contract as compared with current GAAP.

Convertible instruments that continue to be subject to separation

models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition

of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued

with substantial premiums for which the premiums are recorded as paid-in capital.

ASU 2020-06 also amends the guidance for the derivatives

scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions.

will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal

Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within

those fiscal years.

The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company’s

consolidated financial statement presentation or disclosures.

June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326):

Measurement of Credit Losses on Financial

Instruments (“ASC 326”).

The guidance replaces the incurred loss methodology with an expected loss methodology that is referred

to as the current expected credit loss (“CECL”) methodology.

The measurement of expected credit losses under the CECL methodology

is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities.

applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial

guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.

ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as

the credit quality and underwriting standards of a company’s portfolio.

In addition, ASC 326 made changes to the accounting for

available-for-sale debt securities.

One such change is to require credit losses to be presented as an allowance rather than as a write-down

on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required

The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting

The Company has not yet adopted this ASU as it qualifies as a smaller reporting company.

The Company does not expect this

ASU will have a material impact on its consolidated financial statements.

October 2021, the FASB issued ASU 2021-08, “Business Combinations - Accounting for Contract Assets and Contract Liabilities (Topic

The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract

assets and contract liabilities acquired in a business combination.

The amendments in this Update require that an acquirer recognize

and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts

with Customers.

ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal

The Company does not expect the adoption of this ASU to have a material impact on the Company’s financial statements.

FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock

Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40).

ASU 2021-04 provides

guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written

call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.

The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding

equity-classified written call option that remains equity classified.

The amendments in this ASU are effective for the Company for fiscal

years beginning after December 15, 2021.

Early adoption is permitted for all entities, including adoption in an interim period.

does not expect the adoption of this ASU to have a material impact on the Company’s financial statements.

of Operations for the Years Ended April 30, 2023 and 2022

following are the results of our operations for the year ended April 30, 2024 as compared to April 30, 2023:

For the Years Ended

the Years Ended

and marketing expenses

and administrative expenses

(14,472,054 )

Cost of sales

and development costs

operating expenses

Selling and marketing expenses

General and administrative expenses

(14,900,410 )

Research and development costs

Total operating expenses

(26,195,458 )

Loss from operations

from operations

(21,958,775 )

expenses (income):

of debt discount

on conversion of accounts payable to common stock

on change in fair value of derivative liability

(14,119,784 )

Other expenses (income):

Amortization of debt discount

Loss on extinguishment of debt

Loss on issuance of convertible notes

Gain on change in fair value of derivative liability

Gain on change in fair value of contingent consideration

Derivative Expense

Interest expense - related party

Interest expense

Total other (income) expense

Net loss from Continuing Operations

expense - related party

other (income) expense

loss from Continuing Operations

$ (15,636,418 )

2 unchanged sentences

2023, a reduction of 15%.

Net sales consisted partially of shipped orders related to new orders placed and fulfilled to consumers via

our online marketplace and to our international distributors.

The significant decrease in our online consumer marketing of Slinger Bag,

coupled with the general marketplace impact resulting from the increased consumer social mobility following the lifting of all covid

-related restrictions contributed to the significant decrease in sales.

Net sales consisted partially of shipped orders related to new orders placed and fulfilled to consumers

via our online marketplace and to our international distributors.

The significant decrease in our online consumer marketing of

Slinger Bag, coupled with on-going delays in inventory production in Asia, resulting in a significant lack of availability in Q4, all

combined to contribute to the significant decrease in sales as of April 30, 2024.

cost of sales during the year ended April 30, 2024 were $5,004,257, compared to $7,144,335 for the period to April 30, 2023, a reduction

Cost of Sales represents the costs of units shipped during the period.

This reduction in Cost of Sales is a direct result of

the reduction in net sales.

This resulted in a gross profit of $2,778,464, or 28.00%.

compared to a gross profit of $4,224,622, or 26.24%

for the period to April 30, 2022.

The 4.28% in gross profit margin can be attributed to a combination of a reduction in transportation

costs from Asia, compared to the same period in 2022, coupled with a small increase in average selling price of the Slinger Bag units.

This reduction in Cost of Sales is a result of the reduction

in net sales coupled with efficiencies in both our incoming and outgoing product supply chains.

This resulted in a gross profit of $3,393,674,

compared to a gross profit of $2,778,464, or 28% for the period to April 30, 2023.

The 41% in gross profit margin can be attributed

to a combination of a reduction in transportation costs from Asia as well as inland USA, compared to the same period in 2023, coupled

with a small increase in average selling price of the Slinger Bag units.

and marketing expenses

1 unchanged sentence

April 30, 2023, a reduction of 19%.

This decrease is largely driven by a decrease in social media advertising, sponsorships, and other investments in our

public relations presence based on lower cash flows being generated by lower sales.

General and administrative expenses

This decrease is largely driven by a decrease in social media advertising, sponsorships, and other

investments in our market driven primarily by reduced sales and consumer demand stemming from our production delays and significant out

of stock position.

and administrative expenses

and administrative expenses consist primarily of compensation, including share-based compensation, and other employee-related costs,

as well as legal fees and fees for professional services.

During the year ended April 30, 2023, we incurred general and

administrative expenses of $22,743,877 compared with $46,718,986 during the year ended April 30, 2022, a reduction of -51%.

During the year ended April 30, 2024, we incurred general and administrative

expenses of $8,721,823 compared with $22,743,877 during the year ended April 30, 2023, a reduction of 64%.

The decrease in general and

administrative expenses is largely due to a reduction in our share based compensation that resulted in an expense of $31,727,091,

and our impairment loss on the intangible assets and goodwill of Gameface of $11,421,817 in the year ended April 30,

administrative expenses is largely due to a reduction in our share based compensation and reductions in all professional fees and amortization

and development costs

4 unchanged sentences

the year ended April 30, 2023.

$0 gain on change in fair value of contingent consideration and $4,847,000 was recorded during the years

ended April 30, 2023 and 2022.

Excluding the gains, during the years ended April 30, 2023 and 2022, we had other expenses totaling $14,269,067

and $23,222,124, respectively.

The decrease in other expenses for the year ended April 30, 2023 as compared to April 30, 2022 was primarily

due a reduction in amortization of discounts and losses incurred on extinguishment of our debt and convertible notes, a decrease in interest

expense from 2022 to 2023 due to changes in our long-term debt, offset by increases in derivative expense and interest to related parties.

Excluding the gain from the change in the fair value of the derivative liabilities during the years ended

April 30, 2024 and 2023, we had other expenses totaling $16,828,875 and $14,269,067, respectively.

The increase in other expenses for

the year ended April 30, 2024 as compared to April 30, 2023 was primarily due an increase in derivative expenses coupled with increases

in amortization of debt discounts, losses incurred on conversion of accounts payable to common stock, and an increase in interest expense.

operations incorporates the impact of the divestments of both PlaySight and Gameface during the period to April 30, 2024.

1 unchanged sentence

loss from discontinued operations was $0 during the period to April 30,2024 compared to $4,461,968 in the period to April 30, 2023.

Company previously classified Foundation Sports in continuing operations, until December 5, 2022 when they sold 75% of Foundation Sports

back to the original owners at which time it deconsolidated this subsidiary and recorded a loss on the sale.

The Company also determined

to dispose of the PlaySight entity during the year ended April 30, 2023.

The Company completed the sale in November 2022 and recorded

a loss on the sale at that time.

The total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 in the year ended

April 30, 2023.

and Capital Resources

7 unchanged sentences

of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

and Capital Resources

financial statements have been prepared on a going concern basis, which assumes we will be able to realize our assets and discharge our

liabilities in the normal course of business for the foreseeable future.

We had an accumulated deficit of $167,387,028 as of April 30,

2024, and more losses are anticipated in the development of the business.

Accordingly, there is substantial doubt about our ability to

continue as a going concern.

Our financial statements do not include any adjustments related to the recoverability and classification

of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

ability to continue as a going concern is dependent upon our generating profitable operations in the future and/or being able to obtain

3 unchanged sentences

following is a summary of our cash flows from operating, investing and financing activities for the years ended April 30, 2024 and 2023:

For the Years Ended April 30,

Cash flows used in operating activities

the Years Ended April 30,

flows used in operating activities

$ (3,001,433 )

$ (6,365,389 )

Cash flows used in investing activities

flows used in investing activities

$ (16,500,000 )

Cash flows provided by financing activities

flows provided by financing activities

had cash and cash equivalents of $229,705 as of April 30, 2024, as compared to $202,095 as of April 30, 2023.

cash used in operating activities was $6,365,389 during the year ended April 30, 2023, compared with $12,366,700 during the year

ended April 30, 2022.

Our cash used in operating activities during the year ended April 30, 2023 was primarily the result of our net

loss of $71,153,685 for the year which was partially offset by our non-cash expenses of $56,348,619 as well as increases in accounts

receivable, accounts payable, accrued interest and contract liabilities.

cash used in investing activities was $0 for the year ended April, 30 2023, compared with net cash used in investing activities of $1,618,341

for the for year ended April 30, 2022.

Investing activities for the year ended April, 30 2022 mostly related to the issuance of a note

receivable in the amount of $2,250,000, offset by cash received in acquisitions of the entities acquired in fiscal April 30, 2022.

cash provided by financing activities was $5,821,178 for the year ended April 30 2023, compared with $13,734,286 for the year

ended April 30, 2022.

Cash provided by financing activities for the year ended April 30, 2023 consisted of proceeds of $8,744,872

from issuance of common stock, $2,000,000 from notes payable, offset by $4,377,537 in repayments of notes payable and $546,158 in

repayments of notes payable to related parties.

provided by financing activities for the year ended April 30, 2022 consisted of proceeds of $7,500,000 from notes payable and related

party notes payable, $11,000,000 proceeds from convertible notes, offset by $3,965,463 in repayments of notes payable and debt $800,251

of issuance costs on convertible notes.

cash used in operating activities was $3,001,433 during the year ended April 30, 2024, compared with $6,365,389 during the year ended

April 30, 2023.

Our cash used in operating activities during the year ended April 30, 2024 was primarily the result of our net loss for

the years which was partially offset by our non-cash expenses as well as net decreases in inventories, prepaid inventories, prepaid expenses,

other current assets and accounts payable and accrued expenses, offset by net increases in accounts receivable, other current liabilities

and accrued interest.

cash used in investing activities was $16,500,000 for the year ended April, 30 2024, compared with net cash used in investing activities

of $0 for the for year ended April 30, 2023.

Investing activities for the year ended April, 30 2024 related to the acquisition of a 20%

stake in Yuanyu Enterprise Management.

cash provided by financing activities was $19,478,993 for the year ended April 30, 2024, compared with $5,821,178 for the year ended

April 30, 2023.

Cash provided by financing activities for the year ended April 30, 2024 consisted of proceeds of $17,961,828 from issuance

of common stock, $3,728,000 from notes payable, offset by $785,509 in repayments of notes payable and $1,425,326 in repayments of notes

payable to related parties.

provided by financing activities for the year ended April 30, 2023 consisted of proceeds of $8,744,882 from issuance of common stock,

$2,000,000 from notes payable and related party notes payable, offset by $546,158 in payment of notes to related parties and $4,377,537

in notes payable.

Cash Advances

July 29, 2022, the Company entered into two merchant cash advance agreements.

The details of the merchant cash advance agreements are

Company entered into an agreement with Unique Funding Solutions LLC (“UFS”) pursuant to which the Company sold $1,124,250

in future receivables (the “UFS Receivables Purchased Amount”) to UFS in exchange for payment to the Company of $750,000

in cash less fees of $60,000.

The Company agreed to pay UFS $13,491 each week for the first three weeks and thereafter $44,970 per week

until the UFS Receivables Purchased Amount is paid in full.

Company entered into an agreement with Cedar Advance LLC (“Cedar”) pursuant to which the Company sold $1,124,250 in future

receivables (the “Cedar Receivables Purchased Amount”) to Cedar in exchange for payment to the Company of $750,000 in cash

less fees of $60,000.

The Company agreed to pay Cedar $13,491 each week for the first three weeks and thereafter $44,970 per week until

the Cedar Receivables Purchased Amount is paid in full.

June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (“Meged”) pursuant to which

the Company sold $315,689 in future receivables to Meged (the “Meged Receivables Purchased Amount”) to in exchange for

payment to the Company of $210,600 in cash less fees of $10,580.

The Company agreed to pay Meged $17,538 each week until the Meged

Receivables Purchased Amount is paid in full.

the Company sold $315,689 in future receivables to Meged (the “Meged Receivables Purchased Amount”) to in exchange for payment

to the Company of $210,600 in cash less fees of $10,580.

The Company agreed to pay Meged $17,538 each week until the Meged Receivables

Purchased Amount is paid in full.

August 7, 2023, the Company entered into an agreement with UFS (the “UFS Agreement”) pursuant to which the Company sold $797,500

8 unchanged sentences

any of such collateral.

Agreement No.1

November 16, 2023, the Company entered into an agreement with Agile Capital Funding, LLC (the “ACF Agreement”) pursuant to

which the Company sold $693,500 in future receivables to Agile Capital Funding, LLC (the “ACF Receivable Amount”) in exchange

for $450,000 in cash.

The Company agreed to pay Agile Capital Funding, LLC (“ACF”) $28,895.83 each week until the ACF Receivable

Amount is paid in full.

order to secure payment and performance of the Company’s obligations to ACF under the ACF Agreement, the Company granted to ACF

a security interest in the following collateral:

all present and future accounts receivable.

The Company also agreed not to create, incur,

assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

Agreement No.

January 10, 2024, the Company entered into an agreement with ACF (the “Agile Jan Agreement”) pursuant to which the Company

sold $1,460,000 in future receivables to ACF (the “Agile Jan Receivable Amount”) in exchange for $1,000,000 in cash.

Company agreed to pay ACF (“Agile”) $52,142.86 each week until the Agile Receivable Amount is paid in full.

In order to secure

payment and performance of the Company’s obligations to Agile under the Agile Jan Agreement, the Company granted to ACF a security

interest in the following collateral:

all present and future accounts receivable.

The Company also agreed not to create, incur, assume,

or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

The proceeds from the sale of future

receivables were used, in part, to pay the outstanding balance of the ACF Receivable Amount (as defined above).

Agreement No.

January 29, 2024, the Company entered into an agreement with Cedar Advance LLC (the “Cedar Agreement”) pursuant to which

the Company sold $1,183,200 in future receivables to Cedar Advance LLC (the “Cedar Receivable Amount”) in exchange for $752,000

The Company agreed to pay Cedar Advance LLC (“Cedar”) $39,440 each week until the Cedar Receivable Amount is paid

In order to secure payment and performance of the Company’s obligations to Cedar under the Cedar Agreement, the Company

granted to Cedar a security interest in the following collateral:

all present and future accounts receivable.

The Company also agreed

not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

March 6, 2024, the Company entered into an agreement with Unique Funding Solutions (the “UFS Agreement”) pursuant to which

the Company sold $323,350 in future receivables to UFS (the “UFS Receivable Amount”) in exchange for $200,000 in cash.

Company agreed to pay UFS $9,798.49 each week until the UFS Receivable Amount is paid in full.

order to secure payment and performance of the Company’s obligations to UFS under the UFS Agreement, the Company granted to UFS

a security interest in the following collateral:

all present and future accounts receivable.

The Company also agreed not to create, incur,

assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

Agreement No.

April 3, 2024, the Company entered into an agreement with Cedar (the “Second Cedar Agreement”) pursuant to which the Company

sold $438,000 in future receivables to Cedar (the “Second Cedar Receivable Amount”) in exchange for $285,000 in cash.

Company agreed to pay UFS $14,600 each week until the Second Cedar Receivable Amount is paid in full.

order to secure payment and performance of the Company’s obligations to Cedar under the Second Cedar Agreement, the Company granted

to Cedar a security interest in the following collateral:

all present and future accounts receivable.

The Company also agreed not to

create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

Agreement No.

April 22, 2024, the Company entered into an agreement with Cedar (the “Third Cedar Agreement”) pursuant to which the Company

sold $481,800 in future receivables to Cedar (the “Third Cedar Receivable Amount”) in exchange for $310,200 in cash.

Company agreed to pay UFS $18,530.77 each week until the Third Cedar Receivable Amount is paid in full.

order to secure payment and performance of the Company’s obligations to Cedar under the Third Cedar Agreement, the Company granted

to Cedar a security interest in the following collateral:

all present and future accounts receivable.

The Company also agreed not to

create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

of Indebtedness

10 unchanged sentences

the Note are exercisable for up to 90,498 shares of the Company’s common stock.

The Warrants have an exercise price per share

equal to the closing price of the common stock of the Company on the date of the issuance of the Note, or $0.221 per share and a term

of five- and one-half (5½) years following the initial exercise date.

The initial exercise date of the Warrants will be the date

stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq rules.

Pursuant to the terms of the

Loan and Security Agreement, an additional advance of $600,000 may be made by to the Company under the Note.

The Company’s obligations

under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the Company’s subsidiaries

(the “Guarantors”).

The Warrants have an exercise price per share equal

to the closing price of the common stock of the Company on the date of the issuance of the Note, or $4.42 per share and a term of five-

and one-half (5½) years following the initial exercise date.

The initial exercise date of the Warrants was September 13, 2023,

the date stockholder approval was received and effective allowing exercisability of the Warrants under Nasdaq rules.

Pursuant to the

terms of the Loan and Security Agreement, an additional advance of $600,000 was made to the Company under the Note in February 2023.

The Company’s obligations under the terms of the Loan and Security Agreement were fully and unconditionally guaranteed by all of

the Company’s subsidiaries (the “Guarantors”).

October 11, 2023, Connexa Sports Technologies Inc.

(the “Company”) entered into a loan and security modification agreement

(the “Loan and Security Modification Agreement”) with a one or more institutional investors (the “Lenders”) and

a certain institutional investor, as agent for the Lenders (the “Agent”) amending the terms of the Loan and Security Agreement

dated January 6, 2023 (the “LSA”) by and among the Company, the Lenders and the Agent to make an additional loan of $1,000,000

and modify the terms of the LSA to reflect the New Loan.

connection with the Loan and Security Modification Agreement, the Company agreed to issue to the investor warrants (the “Common

Warrants”) to purchase up to 8,460 shares of Common Stock at an exercise price of $19 per share.

The Common Warrants are exercisable

six months after their issuance and will expire five and one-half years from their date of issuance.

The Common Warrants and the shares

of our Common Stock issuable upon the exercise of the Common Warrants are not being registered under the Securities Act of 1933, as amended

(the “Securities Act”), were not offered pursuant to the Registration Statement and were offered pursuant to the exemption

provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder.

The warrants to purchase 8,460 shares of

Common Stock are referred to herein as the “October Warrants”.

previously disclosed, on December 6, 2023, the Company entered into an inducement offer letter agreement (the “Inducement Letter”)

with a certain holder (the “Holder”) whereby the Holder agreed to exercise for

cash warrants to purchase an aggregate of 248,611 shares of Common Stock at a reduced exercise price of $2.94 per share in consideration

of the Company’s agreement to issue new common stock purchase warrants (the “December Warrants” and, together with

the October Warrants, the “Lender’s Warrants”) to purchase up to an aggregate of 497,221 shares of Common Stock at

an exercise price of $5.88 per share (subject to adjustment).

of February 21, 2024, the total amount owed pursuant to the Note was $3,197,335.65.

Of this amount, the Company received gross proceeds

of $3 million from the Lenders.

February 21, 2024, the Company and the Lenders and the Agent entered into a Waiver, Warrant

Amendment and Second Loan and Security Modification Agreement (the “Waiver, Amendment, and Modification Agreement”).

to the Waiver, Amendment, and Modification Agreement, the Lenders and the Agent agreed to

waive certain events of default with regard to certain covenants and obligations the Company had pursuant to (a) that certain registration

rights agreement between the Company and the Lenders and the Agent entered into in September

2022, (b) the Loan and Security Agreement (as modified), and (c) the Inducement Letter.

to the Waiver, Amendment, and Modification Agreement, the Company and the Lenders and the Agent

agreed to modify the Loan and Security Agreement such that the Note became convertible into up to 499,584 shares of Common Stock

based on the agreed to conversion price of $6.40.

The Company believes that the $6.40 conversion price meets the definition of “Minimum

Price” in Nasdaq Listing Rule 5635(d).

On March 26, 2024, the Holder had fully converted the Note into shares of Common Stock and

the Note was fully paid.

Payable - Related Party

6 unchanged sentences

to July 31, 2024.

were $1,953,842 and $2,000,000 in outstanding borrowings from the Company’s related parties for the years ended April 30, 2023

and 2022, respectively.

Accrued interest due to related parties as of April 30, 2023 and 2022 amounted to $917,957 and $908,756,

were $1,169,291and $1,953,842 in outstanding borrowings from the Company’s related parties for the years ended April 30, 2024 and

2023, respectively.

Accrued interest due to related parties as of April 30, 2024 and 2023 amounted to $917,957 and $917,957, respectively.

January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and

Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $103 per ball launcher we sell until we have paid

them an aggregate total of $2,092,700, which represents payment in full of the principal amounts of and accrued interest in respect

of the Loan Agreements (as defined above) and certain other expenses they incurred in connection with the Company.

them an aggregate total of $2,092,700, which represents payment in full of the principal amounts of and accrued interest in respect of

the Loan Agreements (as defined above) and certain other expenses they incurred in connection with the Company.

Sheet Arrangements

5 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 7. Management’s Discussion and Analysis